Carole Sable - Net Worth and Insider Trading

Carole Sable Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carole Sable owns 2 companies in total, including Vitae Pharmaceuticals Inc (VTAE) , and SCYNEXIS Inc (SCYX) .

Click here to see the complete history of Carole Sable’s form 4 insider trades.

Insider Ownership Summary of Carole Sable

Ticker Comapny Transaction Date Type of Owner
VTAE Vitae Pharmaceuticals Inc 2016-10-25 Chief Medical Officer
SCYX SCYNEXIS Inc 2014-05-02 Chief Medical Officer

Carole Sable Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carole Sable Ownership Network

Ownership Network List of Carole Sable

No Data

Ownership Network Relation of Carole Sable


Carole Sable Owned Company Details

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Carole Sable is the Chief Medical Officer of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and director & Chief Executive Officer Jeffrey S. Hatfield .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

Carole Sable Mailing Address

Above is the net worth, insider trading, and ownership report for Carole Sable. You might contact Carole Sable via mailing address: C/o Scynexis, Inc., 3501 C Tricenter Boulevard, Durham Nc 27713.

Discussions on Carole Sable

No discussions yet.